This was further confirmed by the clinical results that histone H3 acetylation of GPER promoter was significantly (p < 0.01) decreased in 5 CRC tissues as compared with patient-matched normal tissues (Fig. 2h). The gene discussed is GPER1; the disease is colorectal carcinoma.